Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China

IMPORTANCE: China, which has one-third of the worldwide smoking population, has a substantial cancer burden, with lung cancer being the leading cause of cancer-related death. The effectiveness of lung cancer screening for mortality reduction has been confirmed, but the cost-effectiveness of diverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zixuan, Wang, Youqing, Wu, Weijia, Yang, Yi, Du, Lingbin, Dong, Hengjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131747/
https://www.ncbi.nlm.nih.gov/pubmed/35608858
http://dx.doi.org/10.1001/jamanetworkopen.2022.13634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131747/
https://www.ncbi.nlm.nih.gov/pubmed/35608858
http://dx.doi.org/10.1001/jamanetworkopen.2022.13634

Ejemplares similares